Vol. 3, 2018

Original research papers



Agnieszka Panek, Justyna Miszczyk

Pages: 10–14

DOI: 10.21175/RadProc.2018.03

One of the main factors that differentiate people in terms of the effectiveness of therapeutic procedures or side effects is the variability in DNA repair capabilities. The aim of the study was to investigate the response of DNA damage repair systems in human lymphocytes irradiated with the therapeutic proton beam in the Bronowice Cyclotron Center of Institute of Nuclear Physics, Polish Academy of Sciences (IFJ PAN) in compare to X-rays. Lymphocytes from healthy donors were irradiated in the Spread-Out Bragg Peak of the proton beam or as reference X-rays. For both sources of radiation, the kinetics of the DNA damage repair capabilities were estimated using the comet assay method (0–120 min) and γ-H2AX test (0-24h). Preliminary results from the comet assay show a similar time and repair efficiency of induced DNA damage for both types of radiation. However, in a group involving X-rays, significant inter-individual differences were observed. With the γ-H2AX test, inter-individual differences in the repair capabilities were not noted. These findings indicate that induced DNA damage repair mechanisms after proton irradiation may be different when compared to X-rays.
  1. N. S. Gavande et al., “DNA repair targeted therapy: the past or future of cancer treatment?,” Pharmacol. Ther., vol. 160, pp. 65 – 83, Apr. 2016.
    DOI: 10.1016/j.pharmthera.2016.02.003
    PMid: 26896565
  2. W. D. Wang et al., “Correlation between DNA repair capacity in lymphocytes and acute side effects to skin during radiotherapy in nasopharyngeal cancer patients,” Clin. Cancer. Res., vol. 11, pp. 5140 – 5145, Jul. 2005.
    DOI: 10.1158/1078-0432.CCR-04-2548
    PMid: 16033828
  3. A. Suetens et al., “Higher initial DNA damage and persistent cell cycle arrest after carbon ion irradiation compared to X-irradiation in prostate and colon cancer cells,” Front. Oncol., vol. 6, pp. 87 – 97, Apr. 2016.
    DOI: 10.3389/fonc.2016.00087
    PMid: 27148479
    PMCid: PMC4830044
  4. J. Praveen et al., “Determination of relative biological effectiveness of 3.2 MeV proton beam from folded tandem ion accelerator,” IJPAP, vol. 50, no. 11, pp. 789 – 792, Nov. 2012.
    Retrieved from: http://nopr.niscair.res.in/handle/123456789/14903;
    Retrieved on: Jun. 12, 2018
  5. E. Pastwa et al., “Repair of radiation-induced DNA double-strand breaks is dependent upon radiation quality and the structural complexity of double-strand breaks,” Radiat. Res., vol. 159, pp. 251 – 261, Feb. 2003.
    DOI: 10.1667/0033-7587(2003)159[0251:RORIDD]2.0.CO;2
  6. I. L. Ibañez et al., “Induction and Rejoining of DNA Double Strand Breaks Assessed by H2AX Phosphorylation in Melanoma Cells Irradiated with Proton and Lithium Beams,” Int. J. Radiat. Oncol. Biol. Phys., vol. 74, no. 4, pp. 1226 – 1235, Jul. 2009.
    DOI: 10.1016/j.ijrobp.2009.02.070
    PMid: 19545788
  7. J. Miszczyk et al., “Response of human lymphocytes to proton radiation of 60 MeV compared to 250 kV X-rays by the cytokinesis-block micronucleus assay,” Radiother. Oncol., vol. 115, pp. 128 – 134, Apr. 2015.
    DOI: org/10.1016/j.radonc.2015.03.003
  8. J. Miszczyk et al., “Do protons and X-rays induce cell-killing in human peripheral blood lymphocytes by different mechanisms?,” Clin. Trans. Rad. Oncol., vol. 9, pp. 23 – 29, Jan. 2018.
    DOI: 10.1016/j.ctro.2018.01.004
    PMid: 29594247
  9. J. Swakoń et al., “Facility for proton radiotherapy of eye cancer at IFJ PAN in Krakow,” Radiat. Meas., vol. 45, pp. 1469 – 1471, 2010.
    DOI: 10.1016/j.radmeas.2010.06.020
  10. S. Sorokina et al., “Relative biological efficiency of protons at low and therapeutic doses in induction of 53BP1/γH2AX foci in lymphocytes from umbilical cord blood,” IJRB, vol. 89, no. 9, pp. 716 – 723, Sep. 2013.
    DOI: 10.3109/09553002.2013.797619
  11. S. Horn, S. Barnard, K. Rothkamm, “Gamma-H2AX-based dose estimation for whole and partial body radiation exposure,” PLoS ONE, vol. 6, no. 9, e25113, Sep. 2011.
    DOI: 10.1371/journal.pone.0025113
  12. A. Cebulska-Wasilewska, “Response to challenging dose of X-rays as a predictive assay for molecular epidemiology,” Mutat. Res., vol. 544, pp. 289 – 297, Nov. 2003.
    DOI: 10.1016/j.mrrev.2003.07.003
    PMid: 14644330
  13. A. Panek et al., “Radiosensitivity and DNA repair in human lymphocytes pre-treated with new radio-protectors (nicotinamide, 1 - methyl -nicotinamide),” in Rapid diagnosis in populations at risk from radiation and chemicals, A. Cebulska-Wasilewska, A. N. Osipov, F. Darroudi, Eds., Amsterdam, Netherlands: IOS Press, 2010, pp. 255 – 261.
  14. A. Panek et al., “Biological effects and inter-individual variability in peripheral blood lymphocytes of healthy donors exposed to 60 MeV proton radiotherapeutic beam,” Int. J. Radiat. Biol., Oct. 2018.
    DOI: 10.1080/09553002.2019.1524941
  15. O. Zlobinskaya et al., “Induction and repair of DNA double-strand breaks assessed by gamma-H2AX foci after irradiation with pulsed or continuous proton beams,” Radiat Environ Biophys., vol. 51, no. 1, pp. 23 – 32, Mar. 2012.
    DOI: 10.1007/s00411-011-0398-1.
  16. G. Borrego-Soto et al., “Ionizing radiation-induced DNA injury and damage detection in patients with breast cancer,” Genet. Mol. Biol., vol. 38, no. 4, pp. 420 – 432, Oct-Dec. 2015.
    DOI: 10.1590/S1415-475738420150019
    PMid: 26692152
  17. O. Mohamad et al., “Carbon ion radiotherapy: a review of clinical experiences and preclinical research, with an emphasis on DNA damage/repair,” Cancers, vol. 9, no. 6, pp. 66 – 96, Jun. 2017.
    DOI: 10.3390/cancers9060066
    PMid: 28598362
  18. R. Fernandez-Gonzalo, S. Baatout, M. Moreels, “Impact of particle irradiation on the immune system: from the clinic to Mars,” Front. Immunol., vol. 8, p. 177, Feb. 2017.
    DOI: 10.3389/fimmu.2017.00177
    PMid: 28275377
  19. S. Diegeler, C. E. Hellweg, “Intercellular communication of tumor cells and immune cells after exposure to different ionizing radiation qualities,” Front. Immunol., vol. 8, pp. 664 – 678, Jun. 2017.
    DOI: 10.3389/fimmu.2017.00664
    PMid: 28638385